Investigation of the effects of redox shuttle inhibition by metformin on gluconeogenic flux rates of lactate and glycerol in humans with type 2 diabetes
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Hepatic gluconeogenic flux (U-13C-lactate tracer) (mg/min)
Timeframe: 2 weeks
Hepatic gluconeogenic flux (glycerol tracer) (mg/min)
Timeframe: 2 weeks